Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-24-111031

President/CEO bought 500 shares at $3.92 ($1,958)

From the SEC's structured data for this filing

Trades in this filing

Gilad Oren · President/CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-23 Purchase : show line 1 in the form +500 $3.92 $1,958 333,395 D
Open-market purchases · 500 sh · avg $3.92 · $1,958
Loading xslF345X05/tm2426748-1_4seq1.xml…